1. Wallace DJ, Furie RA, Tanaka Y, et al.. Baricitinib in systemic lupus erythematosus (SLE): results from a phase 2, randomized, double-blind, placebo-controlled study. EULAR 2018. Abstract OP0019.
Anti-IL-6-therapie bij refractaire gewrichts- en huidbetrokkenheid SSc
jan 2022 | Sclerodermie